Home Products/Services TenFold Benefits Technology Methodology Customers Partners

BioTechnology Communications Education Energy Financial Services Government Healthcare Insurance Manufacturing Services Software Transportation Other

Company Contact Us Support TenFold Forum

TenFold BioTechnology Customers

Isolagen

TenFold built an application to manage Isolagen's clinical trials for its dermal product. Now, that application runs multiple, concurrent clinical trials programs and Isolagen management reports that they are delighted with the ease with which their TenFold-powered application can enhanced and changed. They are also delighted, as well, with the support that they receive from TenFold.

Isolagen, Inc., founded in 1995, is an emerging force in biotechnology by specializing in the development and commercialization of its autologous cellular system (ACS) technology. Their Isolagen Process is a novel process whereby a patient's own collagen-producing cells (fibroblasts) are extracted, reproduced, and then re-introduced by injection back into the patient's treatment area. Unlike other applications for the treatment of dermal defects, the proposed Isolagen® treatment utilizes only the patient's unique, living cells to produce an effect in a minimally invasive and non-surgical way. For more information about Isolagen, please visit www.isolagen.com.

Mehta Partners

Mehta Partners is a leader in global biopharmaceutical investments closely monitoring 400 global companies specializing in innovative therapeutics. Mehta used EnterpriseTenFold to build its Pharma-Biotech database system, which is the backbone of its proprietary research.